Connexin channel modulators and their mechanisms of action

Neuropharmacology

Volumn 75, Issue , 2013, Pages 517-524

  Verselis, Vytas K ^a   Srinivas, Miduturu ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Connexin; Gap junctions; Hemichannels; Pharmacology

Indexed keywords

CARBENOXOLONE; CONNEXIN CHANNEL MODULATOR; FLUFENAMIC ACID; GAP 19 PEPTIDE; GAP 26 PEPTIDE; GAP 27 PEPTIDE; GAP JUNCTION PROTEIN; MEFLOQUINE; PROTEIN DERIVATIVE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

DRUG IDENTIFICATION; DRUG MECHANISM; DRUG SELECTIVITY; DRUG SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

CONNEXIN; GAP JUNCTIONS; HEMICHANNELS; PHARMACOLOGY;

ANIMALS; CONNEXINS; GAP JUNCTIONS; HUMANS; ION CHANNEL GATING; ION CHANNELS; MEMBRANE TRANSPORT MODULATORS;

EID: 84890441799     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.03.020     Document Type: Review

References (98)

1. C.K. Abrams, and S.S. Scherer Gap junctions in inherited human disorders of the central nervous system Biochim. Biophys. Acta 1818 2012 2030 2047
2. C.M. Armstrong Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons J. Gen. Physiol. 58 1971 413 437
3. + channels and its effect on closing rate Proc. Natl. Acad. Sci. U. S. A. 96 1999 4154 4157
4. D. Bai, C. del Corsso, M. Srinivas, and D.C. Spray Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB) J. Pharmacol. Exp. Ther. 319 2006 1452 1458
5. D.L. Beahm, and J.E. Hall Hemichannel and junctional properties of connexin 50 Biophys. J. 82 2002 2016 2031
6. M. Beaumont, and G. Maccaferri Is connexin36 critical for GABAergic hypersynchronization in the hippocampus? J. Physiol. 589 2011 1663 1680
7. S.B. Bodendiek, and G. Raman Connexin modulators and their potential targets under the magnifying glass Curr. Med. Chem. 17 2010 4191 4230
8. S.B. Bodendiek, C. Rubinos, M.P. Trelles, N. Coleman, D.P. Jenkins, H. Wulff, and M. Srinivas Triarylmethanes, a new class of cx50 inhibitors Front. Pharmacol. 3 2012 106
9. D.L. Boger, J.E. Patterson, X. Guan, B.F. Cravatt, R.A. Lerner, and N.B. Gilula Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide Proc. Natl. Acad. Sci. U. S. A. 95 1998 4810 4815
10. S. Boitano, and W.H. Evans Connexin mimetic peptides reversibly inhibit Ca(2+) signaling through gap junctions in airway cells Am. J. Physiol. Lung Cell. Mol. Physiol. 279 2000 L623 L630
11. K. Braet, S. Aspeslagh, W. Vandamme, K. Willecke, P.E. Martin, W.H. Evans, and L. Leybaert Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells J. Cell. Physiol. 197 2003 205 213
12. K. Braet, W. Vandamme, P.E. Martin, W.H. Evans, and L. Leybaert Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26 Cell Calcium 33 2003 37 48
13. R. Bruzzone, M.T. Barbe, N.J. Jakob, and H. Monyer Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes J. Neurochem. 92 2005 1033 1043
14. 2-sensitive and voltage-sensitive Biophys. J. 72 1997 2137 2142
15. F.F. Bukauskas, and V.K. Verselis Gap junction channel gating Biochim. Biophys. Acta 1662 2004 42 60
16. J.M. Burt, and D.C. Spray Volatile anesthetics block intercellular communication between neonatal rat myocardial cells Circ. Res. 65 1989 829 837
17. P.L. Carlen, F. Skinner, L. Zhang, C. Naus, M. Kushnir, and J.L. Perez Velazquez The role of gap junctions in seizures Brain Res. Brain Res. Rev. 32 2000 235 241
18. A.T. Chaytor, W.H. Evans, and T.M. Griffith Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries J. Physiol. 503 Pt 1 1997 99 110
19. B.W. Connors Tales of a dirty drug: carbenoxolone, gap junctions, and seizures Epilepsy Curr. 12 2012 66 68
20. S.J. Cruikshank, M. Hopperstad, M. Younger, B.W. Connors, D.C. Spray, and M. Srinivas Potent block of Cx36 and Cx50 gap junction channels by mefloquine Proc. Natl. Acad. Sci. U. S. A. 101 2004 12364 12369
21. G. Dahl Gap junction-mimetic peptides do work, but in unexpected ways Cell. Commun. Adhes. 14 2007 259 264
22. J.S. Davidson, and I.M. Baumgarten Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships J. Pharmacol. Exp. Ther. 246 1988 1104 1107
23. J.S. Davidson, I.M. Baumgarten, and E.H. Harley Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid Biochem. Biophys. Res. Commun. 134 1986 29 36
24. J. Deleze, and J.C. Herve Effect of several uncouplers of cell-to-cell communication on gap junction morphology in mammalian heart J. Membr. Biol. 74 1983 203 215
25. T. Desplantez, V. Verma, L. Leybaert, W.H. Evans, and R. Weingart Gap26, a connexin mimetic peptide, inhibits currents carried by connexin43 hemichannels and gap junction channels Pharmacol. Res. 65 2012 546 552
26. K.A. Dora, P.E. Martin, A.T. Chaytor, W.H. Evans, C.J. Garland, and T.M. Griffith Role of heterocellular Gap junctional communication in endothelium-dependent smooth muscle hyperpolarization: inhibition by a connexin-mimetic peptide Biochem. Biophys. Res. Commun. 254 1999 27 31
27. L. Ebihara, and E. Steiner Properties of a nonjunctional current expressed from a rat connexin46 cDNA in Xenopus oocytes J. Gen. Physiol. 102 1993 59 74
28. L. Ebihara, X. Liu, and J.D. Pal Effect of external magnesium and calcium on human connexin46 hemichannels Biophys. J. 84 2003 277 286
29. S. Eskandari, G.A. Zampighi, D.W. Leung, E.M. Wright, and D.D. Loo Inhibition of gap junction hemichannels by chloride channel blockers J. Membr. Biol. 185 2002 93 102
30. B.E. Evans, K.E. Rittle, M.G. Bock, R.M. DiPardo, R.M. Freidinger, W.L. Whitter, G.F. Lundell, D.F. Veber, P.S. Anderson, and R.S. Chang Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists J. Med. Chem. 31 1988 2235 2246
31. C. Giaume, and M. Theis Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system Brain Res. Rev. 63 2010 160 176
32. F.M. Gribble, T.M. Davis, C.E. Higham, A. Clark, and F.M. Ashcroft The antimalarial agent mefloquine inhibits ATP-sensitive K-channels Br. J. Pharmacol. 131 2000 756 760
33. N. Haq, D. Grose, E. Ward, O. Chiu, N. Tigue, S.J. Dowell, A.J. Powell, and M.X. Chen A high-throughput assay for connexin 43 (Cx43, GJA1) gap junctions using codon-optimized aequorin Assay Drug Dev. Technol. 11 2013 93 100
34. E.G. Harks, A.D. de Roos, P.H. Peters, L.H. de Haan, A. Brouwer, D.L. Ypey, E.J. van Zoelen, and A.P. Theuvenet Fenamates: a novel class of reversible gap junction blockers J. Pharmacol. Exp. Ther. 298 2001 1033 1041
35. E.G. Harks, J.P. Camina, P.H. Peters, D.L. Ypey, W.J. Scheenen, E.J. van Zoelen, and A.P. Theuvenet Besides affecting intracellular calcium signaling, 2-APB reversibly blocks gap junctional coupling in confluent monolayers, thereby allowing measurement of single-cell membrane currents in undissociated cells Faseb J. 17 2003 941 943
36. A.L. Harris Emerging issues of connexin channels: biophysics fills the gap Q. Rev. Biophys. 34 2001 325 472
37. A.L. Harris, D.C. Spray, and M.V. Bennett Kinetic properties of a voltage-dependent junctional conductance J. Gen. Physiol. 77 1981 95 117
38. D.A. Horton, G.T. Bourne, and M.L. Smythe The combinatorial synthesis of bicyclic privileged structures or privileged substructures Chem. Rev. 103 2003 893 930
39. A. Hung, and I. Yarovsky Gap junction hemichannel interactions with zwitterionic lipid, anionic lipid, and cholesterol: molecular simulation studies Biochemistry 50 2011 1492 1504
40. B.E. Isakson, G.J. Seedorf, R.L. Lubman, W.H. Evans, and S. Boitano Cell-cell communication in heterocellular cultures of alveolar epithelial cells Am. J. Respir. Cell. Mol. Biol. 29 2003 552 561
41. M.M. Jin, and Z. Chen Role of gap junctions in epilepsy Neurosci. Bull. 27 2011 389 406
42. M.F. Johnston, S.A. Simon, and F. Ramon Interaction of anaesthetics with electrical synapses Nature 286 1980 498 500
43. G.R. Juszczak, and A.H. Swiergiel Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 181 198
44. N. Kalcheva, J. Qu, N. Sandeep, L. Garcia, J. Zhang, Z. Wang, P.D. Lampe, S.O. Suadicani, D.C. Spray, and G.I. Fishman Gap junction remodeling and cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia Proc. Natl. Acad. Sci. U. S. A. 104 2007 20512 20516
45. J. Kang, X.L. Chen, L. Wang, and D. Rampe Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG J. Pharmacol. Exp. Ther. 299 2001 290 296
46. K.A. Kleopa, C.K. Abrams, and S.S. Scherer How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? Brain Res. 1487 2012 198 205
47. J. Kronengold, E.B. Trexler, F.F. Bukauskas, T.A. Bargiello, and V.K. Verselis Pore-lining residues identified by single channel SCAM studies in Cx46 hemichannels Cell. Commun. Adhes. 10 2003 193 199
48. J. Kronengold, M. Srinivas, and V.K. Verselis The N-terminal half of the connexin protein contains the core elements of the pore and voltage gates J. Membr. Biol. 245 2012 453 463
49. T. Kwon, A.L. Harris, A. Rossi, and T.A. Bargiello Molecular dynamics simulations of the Cx26 hemichannel: evaluation of structural models with Brownian dynamics J. Gen. Physiol. 138 2011 475 493
50. J.R. Lee, and T.W. White Connexin-26 mutations in deafness and skin disease Expert Rev. Mol. Med. 11 2009 e35
51. Z. Li, Y. Yan, E.A. Powers, X. Ying, K. Janjua, T. Garyantes, and B. Baron Identification of gap junction blockers using automated fluorescence microscopy imaging J. Biomol. Screen. 8 2003 489 499
52. G.S. Liang, M. de Miguel, J.M. Gomez-Hernandez, J.D. Glass, S.S. Scherer, M. Mintz, L.C. Barrio, and K.H. Fischbeck Severe neuropathy with leaky connexin32 hemichannels Ann. Neurol. 57 2005 749 754
53. D. Locke, I.V. Koreen, J.Y. Liu, and A.L. Harris Reversible pore block of connexin channels by cyclodextrins J. Biol. Chem. 279 2004 22883 22892
54. D. Locke, F. Kieken, L. Tao, P.L. Sorgen, and A.L. Harris Mechanism for modulation of gating of connexin26-containing channels by taurine J. Gen. Physiol. 138 2011 321 339
55. S. Maeda, S. Nakagawa, M. Suga, E. Yamashita, A. Oshima, Y. Fujiyoshi, and T. Tsukihara Structure of the connexin 26 gap junction channel at 3.5 A resolution Nature 458 2009 597 602
56. C. Maertens, L. Wei, G. Droogmans, and B. Nilius Inhibition of volume-regulated and calcium-activated chloride channels by the antimalarial mefloquine J. Pharmacol. Exp. Ther. 295 2000 29 36
57. P.E. Martin, C. Wall, and T.M. Griffith Effects of connexin-mimetic peptides on gap junction functionality and connexin expression in cultured vascular cells Br. J. Pharmacol. 144 2005 617 627
58. V.V. Matchkov, A. Rahman, L.M. Bakker, T.M. Griffith, H. Nilsson, and C. Aalkjaer Analysis of effects of connexin-mimetic peptides in rat mesenteric small arteries Am. J. Physiol. Heart Circ. Physiol. 291 2006 H357 H367
59. R.T. Mathias, T.W. White, and X. Gong Lens gap junctions in growth, differentiation, and homeostasis Physiol. Rev. 90 2010 179 206
60. G. Mese, C. Sellitto, L. Li, H.Z. Wang, V. Valiunas, G. Richard, P.R. Brink, and T.W. White The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome Mol. Biol. Cell. 22 2012 4776 4786
61. H. Musa, and R.D. Veenstra Voltage-dependent blockade of connexin40 gap junctions by spermine Biophys. J. 84 2003 205 219
62. H. Musa, J.D. Gough, W.J. Lees, and R.D. Veenstra Ionic blockade of the rat connexin40 gap junction channel by large tetraalkylammonium ions Biophys. J. 81 2001 3253 3274
63. S. Oh, V.K. Verselis, and T.A. Bargiello Charges dispersed over the permeation pathway determine the charge selectivity and conductance of a Cx32 chimeric hemichannel J. Physiol. 586 2008 2445 2461
64. J.A. Orellana, R. von Bernhardi, C. Giaume, and J.C. Saez Glial hemichannels and their involvement in aging and neurodegenerative diseases Rev. Neurosci. 23 2012 163 177
65. W.A. Paznekas, B. Karczeski, S. Vermeer, R.B. Lowry, M. Delatycki, F. Laurence, P.A. Koivisto, L. Van Maldergem, S.A. Boyadjiev, J.N. Bodurtha, and E.W. Jabs GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype Hum. Mutat. 30 2009 724 733
66. C. Picoli, V. Nouvel, F. Aubry, M. Reboul, A. Duchene, T. Jeanson, J. Thomasson, F. Mouthon, and M. Charveriat Human connexin channel specificity of classical and new gap junction inhibitors J. Biomol. Screen. 17 2012 1339 1347
67. J.C. Rekling, X.M. Shao, and J.L. Feldman Electrical coupling and excitatory synaptic transmission between rhythmogenic respiratory neurons in the preBotzinger complex J. Neurosci. 20 2000 RC113
68. N. Rouach, M. Segal, A. Koulakoff, C. Giaume, and E. Avignone Carbenoxolone blockade of neuronal network activity in culture is not mediated by an action on gap junctions J. Physiol. 553 2003 729 745
69. C. Rubinos, H.A. Sanchez, V.K. Verselis, and M. Srinivas Mechanism of inhibition of connexin channels by the quinine derivative N-benzylquininium J. Gen. Physiol. 139 2012 69 82
70. J.E. Saffitz Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling Heart Rhythm 6 2009 S62 S65
71. A. Salameh, and S. Dhein Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim. Biophys. Acta 1719 2005 36 58
72. 2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome J. Gen. Physiol. 136 2010 47 62
73. A. Schmitz, A. Sankaranarayanan, P. Azam, K. Schmidt-Lassen, D. Homerick, W. Hansel, and H. Wulff Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases Mol. Pharmacol. 68 2005 1254 1270
74. N.J. Severs, A.F. Bruce, E. Dupont, and S. Rothery Remodelling of gap junctions and connexin expression in diseased myocardium Cardiovasc. Res. 80 2008 9 19
75. D.C. Spray, and J.M. Burt Structure-activity relations of the cardiac gap junction channel Am. J. Physiol. 258 1990 C195 C205
76. D.C. Spray, A.L. Harris, and M.V. Bennett Equilibrium properties of a voltage-dependent junctional conductance J. Gen. Physiol. 77 1981 77 93
77. D.C. Spray, R. Rozental, and M. Srinivas Prospects for rational development of pharmacological gap junction channel blockers Curr. Drug Targets 3 2002 455 464
78. M. Srinivas, and D.C. Spray Closure of gap junction channels by arylaminobenzoates Mol. Pharmacol. 63 2003 1389 1397
79. M. Srinivas, M.G. Hopperstad, and D.C. Spray Quinine blocks specific gap junction channel subtypes Proc. Natl. Acad. Sci. U. S. A. 98 2001 10942 10947
80. M. Srinivas, J. Kronengold, F.F. Bukauskas, T.A. Bargiello, and V.K. Verselis Correlative studies of gating in Cx46 and Cx50 hemichannels and gap junction channels Biophys. J. 88 2005 1725 1739
81. 2+ signaling J. Neurosci. 26 2006 1378 1385
82. Q. Tang, T.L. Dowd, V.K. Verselis, and T.A. Bargiello Conformational changes in a pore-forming region underlie voltage-dependent "loop gating" of an unapposed connexin hemichannel J. Gen. Physiol. 133 2009 555 570
83. L. Tao, and A.L. Harris 2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32 Mol. Pharmacol. 71 2007 570 579
84. K.R. Tovar, B.J. Maher, and G.L. Westbrook Direct actions of carbenoxolone on synaptic transmission and neuronal membrane properties J. Neurophysiol. 102 2009 974 978
85. + currents by antimalarial drugs in stably transfected HEK293 cells Eur. J. Pharmacol. 484 2004 41 48
86. E.B. Trexler, M.V. Bennett, T.A. Bargiello, and V.K. Verselis Voltage gating and permeation in a gap junction hemichannel Proc. Natl. Acad. Sci. U. S. A. 93 1996 5836 5841
87. J.E. Trosko The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy Biomed. Pharmacother. 59 Suppl. 2 2005 S326 S331
88. V.K. Verselis, and M. Srinivas Divalent cations regulate connexin hemichannels by modulating intrinsic voltage-dependent gating J. Gen. Physiol. 132 2008 315 327
89. V.K. Verselis, C.S. Ginter, and T.A. Bargiello Opposite voltage gating polarities of two closely related connexins Nature 368 1994 348 351
90. V.K. Verselis, M.P. Trelles, C. Rubinos, T.A. Bargiello, and M. Srinivas Loop gating of connexin hemichannels involves movement of pore-lining residues in the first extracellular loop domain J. Biol. Chem. 284 2009 4484 4493
91. J.P. Vessey, M.R. Lalonde, H.A. Mizan, N.C. Welch, M.E. Kelly, and S. Barnes Carbenoxolone inhibition of voltage-gated Ca channels and synaptic transmission in the retina J. Neurophysiol. 92 2004 1252 1256
92. Q. Wang, T. You, D. Yuan, X. Han, X. Hong, B. He, L. Wang, X. Tong, L. Tao, and A.L. Harris Cisplatin and oxaliplatin inhibit gap junctional communication by direct action and by reduction of connexin expression, thereby counteracting cytotoxic efficacy J. Pharmacol. Exp. Ther. 333 2010 903 911
93. 2+ elevation Basic Res. Cardiol. 107 2012 304
94. N. Wang, E. De Vuyst, R. Ponsaerts, K. Boengler, N. Palacios-Prado, J. Wauman, C.P. Lai, M. De Bock, E. Decrock, M. Bol, M. Vinken, V. Rogiers, J. Tavernier, W.H. Evans, C.C. Naus, F.F. Bukauskas, K.R. Sipido, G. Heusch, R. Schulz, G. Bultynck, and L. Leybaert Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury Basic Res. Cardiol. 108 2013 309
95. R. Weingart, and F.F. Bukauskas Long-chain n-alkanols and arachidonic acid interfere with the Vm-sensitive gating mechanism of gap junction channels Pflugers Arch. 435 1998 310 319
96. C.G. Wermuth Selective optimization of side activities: another way for drug discovery J. Med. Chem. 47 2004 1303 1314
97. + channel, IKCa1: a potential immunosuppressant Proc. Natl. Acad. Sci. U. S. A. 97 2000 8151 8156
98. F. Zonta, G. Polles, G. Zanotti, and F. Mammano Permeation pathway of homomeric connexin 26 and connexin 30 channels investigated by molecular dynamics J. Biomol. Struct. Dyn. 29 2012 985 998